Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1642444
PUBLISHER: IMARC | PRODUCT CODE: 1642444
Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2025-2033
PUBLISHED:
PAGES: 126 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global next-generation sequencing (NGS) market size reached USD 23.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 85.4 Billion by 2033, exhibiting a growth rate (CAGR) of 15.5% during 2025-2033. The market for NGS is expanding rapidly due to ongoing technological advancements, increasing use in clinical applications, escalating demand for bioinformatics tools and data analysis solutions, a rising focus on precision medicine, as well as enhanced research and development efforts.
Next-generation sequencing (NGS) is a parallel sequencing technology that determines the sequence of nucleotides in a section of the deoxyribonucleic acid (DNA). It involves various procedures, such as sequencing by synthesis (SBS) and ion semiconductor, single-molecule real-time (SMRT), and nanopore sequencing. It is a cost-effective solution that assists medical professionals in achieving precise results with high accuracy and speed. It also facilitates research in the fields of clinical diagnostics, personalized and genetic medicines, and agriculture and animal studies. At present, it is utilized in pharmacogenomics to escalate the drug delivery process.
Next-Generation Sequencing (NGS) Market Trends:
The growing global geriatric population and the rising prevalence of various chronic medical disorders, such as cancer, cardiovascular, and neurological disorders, represent one of the key factors positively influencing the market. It can also be attributed to the growing use of genetic maps for guiding scientists to analyze the genes that are responsible for medical conditions. In addition, the widespread adoption of liquid biopsies in cancer diagnostics and the increasing utilization of NGS technologies to introduce non-invasive cancer biomarkers for real-time cancer monitoring and detection are creating a positive market outlook. In line with this, continuous technological innovations in sequencers, such as the integration of cloud-computing systems for enhanced data security and management, are strengthening the market growth. Apart from this, continuous financing by governments of various countries to improve healthcare infrastructure is providing a thrust to the market growth. Furthermore, increasing investments by leading players in research and development (R&D) activities for molecular biology, technical engineering, and sequencing chemistry is offering a favorable market outlook.
Next Generation Sequencing Market Segmentation:
Breakup by Sequencing Type:
Whole Genome Sequencing
Targeted Resequencing
Whole Exome Sequencing
RNA Sequencing
CHIP Sequencing
De Novo Sequencing
Methyl Sequencing
Others
Targeted resequencing represents the largest market segment due to the presence of numerous companies in the NGS market offering targeted resequencing services.
Breakup by Product Type:
Instruments
Reagents and Consumables
Software and Services
Reagents and consumables represent the most commonly used product type that assists in sample preparation, DNA isolation, sample cleanup, target enrichment, and quality assurance.
Breakup by Technology:
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Others
Sequencing by synthesis finds extensive applications on account of its high accuracy in performing DNA sequencing and its growing incorporation in NGS instrumentation. In addition, it offers the highest yield of error-free throughput results.
Breakup by Application:
Biomarker and Cancer
Drug Discovery and Personalized Medicine
Genetic Screening
Diagnostics
Agriculture and Animal Research
Others
Biomarker and cancer currently dominate the market due to the rising prevalence of cancer and increasing awareness among individuals about the benefits of early diagnosis and treatment.
Breakup by End-User:
Academic Institutes & Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Academic institutes and research centers account for the majority of the market share due to the increasing application of NGS solutions in research projects.
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market due to the availability of a technologically advanced healthcare research framework in the region, coupled with the presence of multiple clinical laboratories that employ NGS to provide genetic testing services.
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.
Key Questions Answered in This Report
- 1. How big is the next generation sequencing (NGS) market?
- 2. What is the expected growth rate of the global next-generation sequencing (NGS) market during 2025-2033?
- 3. What are the key factors driving the global next-generation sequencing (NGS) market?
- 4. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?
- 5. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?
- 6. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?
- 7. What is the breakup of the global next-generation sequencing (NGS) market based on technology?
- 8. What is the breakup of the global next-generation sequencing (NGS) market based on the application
- 9. What is the breakup of the global next-generation sequencing (NGS) market based on the end-user?
- 10. What are the key regions in the global next-generation sequencing (NGS) market?
- 11. Who are the key players/companies in the global next-generation sequencing (NGS) market?
Product Code: SR112024A2039
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Next-Generation Sequencing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Sequencing Type
- 6.1 Whole Genome Sequencing
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Targeted Resequencing
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Whole Exome Sequencing
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 RNA Sequencing
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 CHIP Sequencing
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 De Novo Sequencing
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Methyl Sequencing
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Others
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
7 Market Breakup by Product Type
- 7.1 Instruments
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Reagents and Consumables
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Software and Services
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Technology
- 8.1 Sequencing by Synthesis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ion Semiconductor Sequencing
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Single-Molecule Real-Time Sequencing
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Nanopore Sequencing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Application
- 9.1 Biomarker and Cancer
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Drug Discovery and Personalized Medicine
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Genetic Screening
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Diagnostics
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Agriculture and Animal Research
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
- 9.6 Others
- 9.6.1 Market Trends
- 9.6.2 Market Forecast
10 Market Breakup by End-User
- 10.1 Academic Institutes & Research Centers
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Hospitals & Clinics
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Pharmaceutical & Biotechnology Companies
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Others
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Agilent Technologies Inc.
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Becton Dickinson and Company
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 10x Genomics
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.4 BGI Group
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.5 Eurofins Scientific
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.6 F. Hoffmann-La Roche AG
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.7 Illumina Inc.
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 Genewiz
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.9 Macrogen Inc.
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.10 Oxford Nanopore Technologies
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 Pacific Biosciences
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.12 Perkinelmer Inc.
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.12.3 Financials
- 16.3.12.4 SWOT Analysis
- 16.3.13 Thermo Fisher Scientific Inc.
- 16.3.13.1 Company Overview
- 16.3.13.2 Product Portfolio
- 16.3.13.3 Financials
- 16.3.13.4 SWOT Analysis
- 16.3.14 Qiagen N.V.
- 16.3.14.1 Company Overview
- 16.3.14.2 Product Portfolio
- 16.3.14.3 Financials
- 16.3.14.4 SWOT Analysis
- 16.3.15 Genapsys Inc.
- 16.3.15.1 Company Overview
- 16.3.15.2 Product Portfolio
- 16.3.1 Agilent Technologies Inc.
Product Code: SR112024A2039
List of Figures
- Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
- Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2024
- Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2024
- Figure 5: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2024
- Figure 6: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2024
- Figure 7: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2024
- Figure 8: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2024
- Figure 9: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 10: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Next-Generation Sequencing (Other Sequencing Types) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Next-Generation Sequencing (Other Sequencing Types) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Global: Next-Generation Sequencing (Biomarker and Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Global: Next-Generation Sequencing (Biomarker and Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: North America: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: North America: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: United States: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: United States: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Canada: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Canada: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Asia Pacific: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Asia Pacific: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: China: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: China: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Japan: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Japan: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: India: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: India: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: South Korea: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: South Korea: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Australia: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Australia: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 80: Indonesia: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 81: Indonesia: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 82: Others: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 83: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 84: Europe: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 85: Europe: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 86: Germany: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 87: Germany: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 88: France: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 89: France: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 90: United Kingdom: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 91: United Kingdom: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 92: Italy: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 93: Italy: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 94: Spain: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 95: Spain: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 96: Russia: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 97: Russia: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 98: Others: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 99: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 100: Latin America: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 101: Latin America: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 102: Brazil: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 103: Brazil: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 104: Mexico: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 105: Mexico: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 106: Others: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 107: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 108: Middle East and Africa: Next-Generation Sequencing Market: Sales Value (in Million USD), 2019 & 2024
- Figure 109: Middle East and Africa: Next-Generation Sequencing Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 110: Global: Next-Generation Sequencing Industry: SWOT Analysis
- Figure 111: Global: Next-Generation Sequencing Industry: Value Chain Analysis
- Figure 112: Global: Next-Generation Sequencing Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
- Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million USD), 2025-2033
- Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million USD), 2025-2033
- Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million USD), 2025-2033
- Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 8: Global: Next-Generation Sequencing Market Structure
- Table 9: Global: Next-Generation Sequencing Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.